How Has The Unit Dose Manufacturing Market Size Evolved Historically?
The unit dose manufacturing market has seen considerable growth due to a variety of factors.
•There has been remarkable expansion in the market size of unit dose manufacturing in recent times. Its growth is projected to surge from $32.82 billion in 2024 to $39.7 billion in 2025, representing a compound annual growth rate (CAGR) of 21.0%.
The growth experienced during the historic period can be traced back to old-fashioned pharmaceutical manufacturing practices, changes in drug packaging regulations, an uptick in the need for personalized medicine, the rise in the aging population, and a higher occurrence of chronic diseases.
What Will Be The Unit Dose Manufacturing Market Size In The Future?
The unit dose manufacturing market is expected to maintain its strong growth trajectory in upcoming years.
• Expectations for the unit dose manufacturing market are set high as significant growth is projected in upcoming years. By 2029, the market is forecasted to reach $88.11 billion, with a compound annual growth rate (CAGR) of 22.1%.
The anticipated growth during this forecast period is due to various factors, including the integration of Industry 4.0 into pharmaceutical manufacturing, the focus on personalized and precision medicine, regulatory emphasis on the safety and efficacy of drugs, the expansion of pharmaceutical outsourcing, and an increasing demand for patient-oriented drug delivery. Future trends during this period are set to involve further automation in unit dose manufacturing, the incorporation of IoT in pharmaceutical packaging, customized unit dose packaging per specific drug requirements, the use of sustainable and environmentally friendly packaging materials, and the advancement of 3D printing in personalized drug manufacturing.
What Key Factors and Trends are Driving the Growth of the Unit Dose Manufacturing Market?
The expected surge in healthcare expenditure is set to fuel the expansion of the unit dose manufacturing market. Health spending encompasses all expenses connected to the provision of health services, emergency aid oriented towards health, nutrition schemes, and family planning activities. The escalation in healthcare expenditure will aid the progression and improvement of a host of health-related services, one of which is unit dose manufacturing, thereby positively influencing market growth. For example, as per the data released by Cross River Therapy, a American ABA therapy service provider, in September 2024, the U.S pharmaceutical industry made $550 billion, and Americans spent $576.9 billion on medicine in 2021, this figure is forecasted to climb to $605-$635 billion by 2025. Hence, the upward trend in healthcare spending is a key driver for the expansion of the unit dose manufacturing market.
What are the Market Segments in the Unit Dose Manufacturing Market?
The unit dose manufacturing market covered in this report is segmented –
1) By Product: Liquid Unit Dose, Solid Unit Dose, Other Products
2) By Sourcing: In-House, Outsourcing
3) By End-User: Independent Pharmacies, Long Term Care Facility, Hospitals, Other End-Users
Subsegments:
1) By Liquid Unit Dose: Liquid Vials, Ampoules, Pre-filled Syringes
2) By Solid Unit Dose: Tablets, Capsules, Powder Packs
3) By Other Products: Transdermal Patches, Inhalation Doses, Creams And Ointments In Unit Dose Packaging
Pre-Book The Unit Dose Manufacturing Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends are Shaping the Unit Dose Manufacturing Market?
A significant trend emerging in the unit-dose manufacturing market is product innovation. In order to stay competitive, major players in the market are creating new, innovative products. For example, in August 2024, Eli Lilly and Company, a pharmaceutical firm in the US, introduced Zepbound (tirzepatide) 2.5 mg and 5 mg single-dose vials for patients paying out-of-pocket with a prescription. This extension of accessibility serves to meet an increased demand for the product. Providing these vials at a discount of 50% or more allows it to be more affordable in comparison to other GLP-1 obesity treatments. This budget-friendly option opens up access to a substantial number of adults with obesity, including those who are not eligible for the Zepbound savings card, those without insurance from an employer, and those paying without any insurance coverage.
Who Are the Key Players in the Unit Dose Manufacturing Market?
Major companies operating in the unit dose manufacturing market include:
• Nipro Corporation
• Thermo Fisher Scientific Inc.
• Amcor plc
• Berry Global
• CCL Industries
• Sealed Air Corporation
• Huhtamäki Oyj
• Catalent Inc.
• AptarGroup
• Schott AG
• West Pharmaceuticals Services Inc.
• Constantia Flexibles Group GmbH
• Gerresheimer AG
• RPC Group
• Klöckner Pentaplast Group
• Stevanato Group
• Bemis Company
• Corden Pharma GmbH
• LTS Lohmann Therapie-Systeme AG
• PCI Pharma Services
• Comar LLC
• Renaissance Lakewood LLC
• Mikart LLC
• Tapemark Company Inc.
• Bilcare Research
• Medical Packaging Inc
• American Health Packaging
• Aphena Pharma Solutions
What are the Regional Insights into the Unit Dose Manufacturing Market?
North America was the largest region in the unit dose manufacturing market in 2024. The regions covered in the unit dose manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
